| Literature DB >> 26410077 |
Andy Maun1,2,3, Catrin Wessman4,5, Pär-Daniel Sundvall6,7, Jörgen Thorn8, Cecilia Björkelund9.
Abstract
BACKGROUND: Primary healthcare in Sweden has undergone comprehensive reforms, including freedom of choice regarding provider, freedom of establishment and increased privatisation aiming to meet demands for quality and availability. In this system privately and publicly owned primary care centres with different business models (for-profit vs non-profit) coexist and compete for patients, which makes it important to study whether or not the type of ownership influences the quality of the primary healthcare services.Entities:
Mesh:
Year: 2015 PMID: 26410077 PMCID: PMC4583720 DOI: 10.1186/s12913-015-1082-y
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Demographic characteristics of privately and publicly owned primary care centres (PCC)
| Privately owned PCC | Publicly owned PCC | all PCC | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| no. of PHCC | no. of listed citizens, (% of the pop.) | mean listed citizens/PHCC (SD) | no. of PHCC | no. of listed citizens, (% of the pop.) | mean listed citizens/PHCC (SD) | no. of PHCC | no. of listed citizens, (% of the pop.) | mean listed citizens/PHCC (SD) | |||||||
| April 2011 | 86 | 510,123 (32.1 %) | 5931.7 (3426.29) | 114 | 1,075,225 (67.6 %) | 9431.8 (3931.52) | 200 | 1,585,348 (99.7 %) | 7926.7 (4099.90) | ||||||
| January 2014 | 87 | 580,304 (35.9 %) | 6670.2 (3495.72) | 114 | 1,032,359 (63.9 %) | 9055.8 (3768,60) | 201 | 1,612,663 (99.9 %) | 8023.2 (3830.67) | ||||||
| Change, (RG) | +1 (+1.1 %) | +70,181 (+12.1 %) | +738.5 (+11,1 %) | 0 (0) | −42,866 (−4.2 %) | −375 (–4.2 %) | +1 (+0.5 %) | +27,315 (+1.7 %) | 96.5 (+1.2 %) | ||||||
| geographic location: within or outside the regional metropolis, percentage of PCCs within their group | |||||||||||||||
| within | outside | within | outside | within | outside | ||||||||||
| 56.9 % | 43.1 % | 34.5 % | 65.5 % | 44.0 % | 56.0 % | ||||||||||
| gender in percentage of listed citizens | |||||||||||||||
| female | male | female | male | female | male | ||||||||||
| April 2011 | 49.61 % (0.035) | 50.39 % (0.035) | 49.83 % (0.018) | 50.17 % (0.018) | 49.72 % (0.027) | 50.28 % (0.027) | |||||||||
| January 2014 | 49.55 % (0.036) | 50.45 % (0.036) | 49.78 % (0.018) | 50.22 % (0.018) | 49.68 % (0.027) | 50.32 % (0.027) | |||||||||
| fraction of citizens within each group belonging to age groups (aged 0–19, 20–64, >64) | |||||||||||||||
| 0–19 | 20–64 | >64 | 0–19 | 20–64 | >64 | 0–19 | 20–64 | >64 | |||||||
| April 2011 | 20.1 % (0.06) | 62.4 % (0.08) | 17.5 % (0.06) | 23.4 % (0.04) | 56.2 % (0.05) | 20.4 % (0.05) | 21.9 % (0.06) | 58.9 % (0.08) | 19.2 % (0.06) | ||||||
| January 2014 | 20.0 % (0.06) | 62.4 % (0.08) | 17.6 % (0.06) | 23.4 % (0.04) | 56.0 % (0.05) | 20.6 % (0.05) | 21.9 % (0.06) | 58.8 % (0.07) | 19.3 % (0.06) | ||||||
| mean of Care Need Index | |||||||||||||||
| April 2011 | 2.36 (0.912) | 2.32 (0.632) | 2.34 (0.762) | ||||||||||||
| January 2014 | 2.36 (1.034) | 2.30 (0.667) | 2.33 (0.844) | ||||||||||||
| fraction of citizens within each group listed at PCC belonging to quintile 1–5 of Care Need Index (1 = most affluent, 5 = least affluent) | |||||||||||||||
| CNI Q1 | CNI Q2 | CNI Q3 | CNI Q4 | CNI Q5 | CNI Q1 | CNI Q2 | CNI Q3 | CNI Q4 | CNI Q5 | CNI Q1 | CNI Q2 | CNI Q3 | CNI Q4 | CNI Q5 | |
| 21 % | 26 % | 18 % | 12 % | 22 % | 21 % | 14 % | 19 % | 25 % | 22 % | 21 % | 18 % | 19 % | 21 % | 22 % | |
| Completeness of outcome measurement datasets for presciptions | |||||||||||||||
| Prescription data of: | number of datasets | missing | completeness | number of datasets | missing | completeness | number of datasets | missing | completeness | ||||||
| Antibiotics | 2765 | 171 | 93.82 % | 3732 | 117 | 96.86 % | 6497 | 288 | 95.57 % | ||||||
| Benzodiazepines (20–74yo) | 2769 | 167 | 93.97 % | 3732 | 117 | 96.86 % | 6501 | 284 | 95.63 % | ||||||
| Benzodiazepines (>74yo) | 2743 | 193 | 92.96 % | 3732 | 117 | 96.86 % | 6475 | 310 | 95.21 % | ||||||
| Patient Perceived Quality (PPQ) (min 0- max 100 points) | |||||||||||||||
| PPQ dataset completeness 99.11 % | PPQ dataset completeness 96.25 % | PPQ dataset completeness 97.40 % | |||||||||||||
| mean PPQ | recommend PCC | access | continuity | mean PPQ | recommend PCC | access | continuity | mean PPQ | recommend PCC | access | continuity | ||||
| 2011 | 82.4 (6.21) | 86.3 (7.93) | 84.7 (9.59) | 70.4 (14.39) | 79.6 (5.62) | 81.7 (7.85) | 80.18 (9.45) | 58.2 (13.86) | 80.8 (6.01) | 83.6 (8.18) | 82.1 (9.75) | 63.2 (15.27) | |||
| 2012 | 81.5 (6.35) | 85.1 (9.03) | 82.2 (10.47) | 68.9 (14.14) | 78.4 (5.63) | 79.5 (8.34) | 78.4 (9.47) | 57.6 (14.01) | 79.7 (6.12) | 81.9 (9.04) | 80.0 (10.05) | 62.4 (15.11) | |||
| 2013 | 81.4 (6.23) | 84.7 (8.66) | 78 (11.81) | 68.1 (12.96) | 77.9 (6.77) | 79.0 (9.84) | 77.5 (10.24) | 57.1 (15.13) | 79.4 (6.75) | 81.4 (9.75) | 77.9 (10.91) | 61.8 (15.22) | |||
Sample sizes, location and listed population with age, gender och socioeconomic characteristics. Completeness of datasets for drug prescription data. Results of the National Survey on Patient Perceived Quality (PPQ). Unless otherwise stated standard deviations in brackets. Abbreviations used in the table: PCC = primary care centre, no. = number, pop . = population, SD = standard deviation, RG = relative growth 2014 compared to 2011, PPQ = Patient Perceived Quality, yo = years old, IHD = Ischemic heart disease, CNI Q1–5 Care Need Index quintile 1–5
Fig. 1Listing or sign off at privately and publicly owned healthcare centres
Fig. 2Changes in recent listing between April 2011 and January 2014 by socioeconomic quintiles
Adjustments for Care Need Index, gender, age structure, size and location of primary care centre
| Patient perceived Quality (mean) | Prescription rates of benzodiazepine derivates for patients aged 20–74 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Effect | Estimate | Standard error | 95 % confidence interval | Effect | Estimate | Standard error | 95 % confidence interval | ||
| Lower | Upper | Lower | Upper | ||||||
| Intercept | 92.17 | 1.505 | 89.20 | 95.14 | Intercept | −149.95 | 119.807 | −385.27 | 85.36 |
| Publicly owned | −2.24 | 0.858 | −3.93 | −0.56 | Publicly owned | 12.79 | 17.732 | −22.03 | 47.62 |
| Privately owned | 0 | Privately owned | 0 | ||||||
| Year, 2011 | 1.10 | 0.568 | −0.02 | 2.22 | Year, 2011 | −12.49 | 19.367 | −50.53 | 25.55 |
| Year, 2012 | 0.16 | 0.558 | −0.94 | 1.26 | Year, 2012 | −5.42 | 18.869 | −42.48 | 31.64 |
| Year, 2013 | 0 | Year, 2013 | 0 | ||||||
| Publicly owned * year, 2011 | 0.69 | 0.738 | −0.76 | 2.14 | Publicly owned * year, 2011 | 4.4 | 25.219 | −45.14 | 53.93 |
| Publicly owned * year, 2012 | 0.44 | 0.730 | −0.99 | 1.88 | Publicly owned * year, 2012 | 3.94 | 24.819 | −44.8 | 52.69 |
| Publicly owned * year, 2013 | 0 | Publicly owned * year, 2013 | 0 | ||||||
| Privately owned * year, 2011 | 0 | Privately owned * year, 2011 | 0 | ||||||
| Privately owned * year, 2012 | 0 | Privately owned * year, 2012 | 0 | ||||||
| Privately owned * year, 2013 | 0 | Privately owned * year, 2013 | 0 | ||||||
| CNI | −3.48 | 0.465 | −4.40 | −2.57 | CNI | 22.01 | 6.986 | 8.29 | 35.73 |
| within regional metropolis | −1.78 | 0.732 | −3.23 | −0.34 | Proportion female | 821.64 | 234.167 | 361.7 | 1281.58 |
| outside regional metropolis | 0 | Proportion male | 0 | ||||||
| number of listed citizens (in 100) | −0.03 | 0.010 | −0.05 | −0.01 | within regional metropolis | −50.99 | 10.714 | −72.03 | −29.95 |
| outside regional metropolis | 0 | ||||||||
| Prescription rates of benzodiazepine derivates for patients aged over 74 | |||||||||
| Prescription rates of antibiotics | |||||||||
| Effect | Estimate | Standard error | 95 % confidence interval | ||||||
| Lower | Upper | ||||||||
| Intercept | 5.89 | 2.426 | 1.13 | 10.66 | |||||
| Publicly owned | −1.3 | 0.271 | −1.83 | −0.77 | Effect | Estimate | Standard Error | 95 % confidence interval | |
| Privately owned | 0 | Lower | Upper | ||||||
| Year, 2011 | 0.89 | 0.287 | 0.33 | 1.46 | Intercept | 602.43 | 450.151 | −281.74 | 1486.59 |
| Year, 2012 | 0.89 | 0.280 | 0.34 | 1.44 | Publicly owned | 50.98 | 66.624 | −79.88 | 181.84 |
| Year, 2013 | 0 | Privately owned | 0 | ||||||
| Publicly owned * year, 2011 | −0.49 | 0.374 | −1.23 | 0.24 | Year, 2011 | −201.67 | 72.766 | −344.59 | −58.75 |
| Publicly owned * year, 2012 | −0.43 | 0.368 | −1.15 | 0.3 | Year, 2012 | −135.76 | 70.896 | −275 | 3.49 |
| Publicly owned * year, 2013 | 0 | Year, 2013 | 0 | ||||||
| Privately owned * year, 2011 | 0 | Publicly owned * year, 2011 | 134.16 | 94.756 | −51.96 | 320.27 | |||
| Privately owned * year, 2012 | 0 | Publicly owned * year, 2012 | 76.66 | 93.253 | −106.5 | 259.82 | |||
| Privately owned * year, 2013 | 0 | Publicly owned * year, 2013 | 0 | ||||||
| CNI | 0.57 | 0.109 | 0.36 | 0.78 | Privately owned * year, 2011 | 0 | |||
| Proportion female | 3.8 | 3.555 | −3.18 | 10.78 | Privately owned * year, 2012 | 0 | |||
| Proportion male | 0 | Privately owned * year, 2013 | 0 | ||||||
| Proportion of 0-19 | 0.95 | 1.877 | −2.73 | 4.64 | CNI | 119.38 | 26.248 | 67.83 | 170.94 |
| Proportion of 20-64 | −5.19 | 1.811 | −8.74 | −1.63 | Proportion female | 1637.02 | 879.835 | −91.1 | 3365.14 |
| Proportion of 65+ | 0 | Proportion male | 0 | ||||||
| within regional metropolis | −0.8 | 0.183 | −1.15 | −0.44 | within regional metropolis | 212.03 | 40.256 | 132.96 | 291.1 |
| outside regional metropolis | 0 | outside regional metropolis | 0 | ||||||
The estimates of the mean patient perceived quality, prescription rates of antibiotics and benzodiazepine derivatives per ownership type are calculated by a linear mixed model for repeated yearly observations (for the 197 PCCs with data during 2011–2013). Adjustments were made selectively for year, location, number of listed citizens (in 100), Care Need Index, proportion of gender group listed and proportion of age groups listed at PCC (0–19 years, 20–64 years and 65+). * indicates the interaction of two effects
Fig. 3Number of purchased prescriptions of antibiotics for a 3-month period/100 listed. Using the raw data to plot the 10th (dashed line), 50th (solid line) and 90th percentile (dotted line) respectively
Prescription of benzodiazepine derivates
| For individuals aged between 20–74 | For individuals >74 years of age | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Year | Type of owner-ship | Mean DDD | Standard deviation | Increase- rate compared to 2011 | Deviation from mean DDD for all PCCs | Mean DDD | Standard deviation | Increase-rate compared to 2011 | Deviation from mean DDD for all PCCs |
| 2011 | publicly | 299.20 | 103.04 | 4.83 % | 1751.85 | 445.74 | 2.70 % | ||
| privately | 266.64 | 162.59 | −6.58 % | 1643.16 | 740.16 | −3.68 % | |||
| all PCCs | 285.42 | 132.49 | 1705.88 | 590.77 | |||||
| 2012 | publicly | 309.19 | 105.49 | 3.34 % | 3.91 % | 1775.69 | 440.47 | 1.36 % | 1.23 % |
| privately | 281.73 | 151.34 | 5.66 % | −5.32 % | 1724.35 | 578.87 | 4.94 % | −1.70 % | |
| all PCCs | 297.55 | 127.65 | 4.25 % | 1754.10 | 503.86 | 2.83 % | |||
| 2013 | publicly | 306.22 | 101.55 | 2.35 % | 3.55 % | 1833.08 | 433.27 | 4.64 % | 0.03 % |
| privately | 281.83 | 144.04 | 5.70 % | −4.70 % | 1831.66 | 567.52 | 11.47 % | −0.04 % | |
| all PCCs | 295.74 | 122.21 | 3.61 % | 1832.47 | 494.94 | 7.42 % | |||
| Total | publicly | 305.56 | 103.46 | 4.00 % | 1790.97 | 440.33 | 1.12 % | ||
| privately | 277.98 | 151.66 | −5.39 % | 1744.23 | 623.95 | −1.52 % | |||
| all PCCs | 293.81 | 126.98 | 1771.17 | 526.45 | |||||
Purchased prescriptions in defined daily doses (DDD) per 100 listed individuals at PCC, divided into age-group, year and type of ownership
Percentage of documented follow-ups carried out for certain chronic diseases
| Chronic disease | Patients with documentation for | Year | Privately owned PCC | Publicly owned PCC | ||||
|---|---|---|---|---|---|---|---|---|
| Percentage mean | SD | Percentage data completeness | Percentage mean | SD | Percentage data completeness | |||
| Diabetes mellitus (DM) | HbA1c measurement | 2011 | 91.1 | 8.53 | 98.8 | 90.8 | 8.06 | 100.0 |
| 2012 | 92.9 | 7.63 | 100.0 | 92.5 | 5.20 | 100.0 | ||
| 2013 | 94.5 | 5.40 | 98.8 | 94.2 | 5.78 | 100.0 | ||
| blood pressure | 2011 | 90.7 | 7.99 | 98.8 | 90.2 | 7.80 | 100.0 | |
| 2012 | 92.9 | 8.09 | 100.0 | 92.9 | 4.26 | 100.0 | ||
| 2013 | 93.6 | 7.19 | 98.8 | 94.5 | 4.17 | 100.0 | ||
| body mass index | 2011 | 82.9 | 12.96 | 98.8 | 84.4 | 9.96 | 100.0 | |
| 2012 | 92.9 | 12.01 | 100.0 | 87.3 | 7.68 | 100.0 | ||
| 2013 | 93.6 | 9.07 | 98.8 | 89.8 | 6.79 | 100.0 | ||
| smoking status | 2011 | 84.9 | 12.64 | 98.8 | 85.4 | 10.73 | 100.0 | |
| 2012 | 89.1 | 11.39 | 100.0 | 87.9 | 8.79 | 100.0 | ||
| 2013 | 88.9 | 9.46 | 98.8 | 89.7 | 8.97 | 100.0 | ||
| micro-albumin urine test | 2011 | 59.4 | 24.54 | 98.8 | 74.2 | 17.73 | 100.0 | |
| 2012 | 68.4 | 22.49 | 100.0 | 75.6 | 17.28 | 100.0 | ||
| 2013 | 70.6 | 19.3 | 98.8 | 76.7 | 16.46 | 100.0 | ||
| low-density lipoprotein | 2011 | 67.9 | 16.75 | 98.8 | 71.4 | 14.49 | 100.0 | |
| 2012 | 71.6 | 17.36 | 100.0 | 74.9 | 13.67 | 100.0 | ||
| 2013 | 76.1 | 13.91 | 98.8 | 77.0 | 12.89 | 100.0 | ||
| average percentage | 83.4 | 12.60 | 99.2 | 85.0 | 10.04 | 100.0 | ||
| Ischemic heart disease (IHD) | blood pressure | 2012 | 82.5 | 8.27 | 89.7 | 84.1 | 6.23 | 99.1 |
| smoking status | 2012 | 53.0 | 17.52 | 78.9 | 59.1 | 14.06 | 98.2 | |
| low-density lipoprotein | 2012 | 55.3 | 16.20 | 71.6 | 60.5 | 12.94 | 99.1 | |
| average percentage | 63.6 | 14.00 | 80.1 | 67.9 | 11.08 | 98.8 | ||
| Hypertension (absence of DM and IHD) | blood pressure | 2012 | 82.4 | 9.14 | 96.4 | 83.9 | 7.45 | 99.1 |
| smoking status | 2012 | 50.8 | 21.12 | 93.8 | 57.8 | 14.5 | 99.1 | |
| average percentage | 66.6 | 15.13 | 95.1 | 70.9 | 10.98 | 99.1 | ||
SD = standard deviation